✦ LIBER ✦

Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes

✍ Scribed by B. W. Bode; M. A. Testa; M. Magwire; P. M. Hale; M. Hammer; L. Blonde; A. Garber; on behalf of the LEAD-3 Study Group

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liraglutide, a once-daily human glucagon

✍ A. Garber; R. R. Henry; R. Ratner; P. Hale; C. T. Chang; B. Bode 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 971 KB

Weight loss with liraglutide, a once-dai

✍ J. Jendle; M. A. Nauck; D. R. Matthews; A. Frid; K. Hermansen; M. Düring; M. Zdr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

Improved glycaemic control of thrice-dai

✍ M. R. Clements; J. Tits; B. T. Kinsley; J. Råstam; H. H. Friberg; R. J. Ligthelm 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB